Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer

被引:37
作者
Petrik, DW
McCready, DR
Sawka, CA
Goel, V
机构
[1] Princess Margaret Hosp, Dept Surg Oncol, Toronto, ON M5G 2M9, Canada
[2] Univ Alberta, Dept Radiat Oncol, Edmonton, AB, Canada
[3] Univ Hlth Network, Div Gen Surg, Toronto, ON, Canada
[4] Univ Toronto, Dept Med, Toronto, ON, Canada
[5] Toronto Sunnybrook Reg Canc Ctr, Toronto, ON, Canada
[6] Inst Clin Evaluat Sci, Toronto, ON, Canada
[7] Univ Toronto, Dept Hlth Adm, Toronto, ON M5S 1A1, Canada
[8] Univ Toronto, Dept Publ Hlth Sci, Toronto, ON M5S 1A1, Canada
关键词
breast neoplasms; lymph node excision; axilla; academic medical centers; treatment outcome; lymphatic metastases;
D O I
10.1002/jso.10198
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Objectives: Axillary lymph node dissection (ALND) in patients with breast cancer is crucial for accurate staging, provides excellent regional tumor control, and is included in the standard of care for the surgical treatment of breast cancer. However, the extent of ALND varies, and the extent of dissection and the number of lymph nodes that comprise an optimal axillary dissection are under debate. Despite conflicting evidence, several studies have shown that improved survival is correlated with more lymph nodes removed in both node-negative and node-positive patients. The purpose of this study is to determine which patient, tumor, surgeon, and hospital characteristics are associated with the number of nodes excised in early breast cancer patients. Methods: A random sample of 938 women with node-negative breast cancer was drawn from the Ontario Cancer Registry and the data supplemented with chart reviews. The extent of axillary dissection was studied by examining the number of nodes examined in relation to the patient, tumor, surgeon, and hospital factors. Results: The mean number of lymph nodes excised was 9.8 (SD = 4.8; range, 1-31), and 49% of patients had greater than or equal to 10 nodes excised. Lower patient age was associated with the excision of more lymph nodes ( greater than or equal to10 nodes: 63% of patients <40 years vs. 38% of patients greater than or equal to80 years). Surgeon academic affiliation and surgery in a teaching hospital were highly correlated with each other and were significantly associated with the excision of greater than or equal to10 nodes. The number of nodes excised was not associated with any tumor factors, nor with the breast operation performed. These results were confirmed with multivariable models. Conclusions: Even though the number of lymph nodes found in the pathologic specimen can be influenced by factors other than surgical technique (e.g., number of nodes present, specimen handling, and pathologic examination), this study shows significant variation of this variable and an association with several patient and surgeon/hospital factors. This variation and the association with survival warrant further study and effort at greater consistency. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:84 / 90
页数:7
相关论文
共 54 条
[1]  
[Anonymous], 1991, IARC Sci Publ
[2]   TREATMENT OF EARLY BREAST-CANCER - REPORT AFTER 10 YEARS OF A CLINICAL TRIAL [J].
ATKINS, H ;
WAYTE, AB ;
HAYWARD, JL ;
KLUGMAN, DJ .
BRITISH MEDICAL JOURNAL, 1972, 2 (5811) :423-&
[3]  
AUGUST DA, 1997, SURG SCI PRINCIPLES, P1357
[4]   AXILLARY DISSECTION OF LEVEL-I AND LEVEL-II LYMPH-NODES IS IMPORTANT IN BREAST-CANCER CLASSIFICATION [J].
AXELSSON, CK ;
MOURIDSEN, HT ;
ZEDELER, K .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (8-9) :1415-1418
[5]  
BALL ABS, 1992, ANN ROY COLL SURG, V74, P126
[6]   Surgeon variability in treating nonpalpable breast cancer: Surgical oncology as a value-added specialty [J].
Blair, SL ;
O'Shea, KE ;
Orr, RK .
ANNALS OF SURGICAL ONCOLOGY, 1998, 5 (01) :28-32
[7]   VALUE OF AXILLARY DISSECTION IN ADDITION TO LUMPECTOMY AND RADIOTHERAPY IN EARLY BREAST-CANCER [J].
CABANES, PA ;
SALMON, RJ ;
VILCOQ, JR ;
DURAND, JC ;
FOURQUET, A ;
GAUTIER, C ;
ASSELAIN, B .
LANCET, 1992, 339 (8804) :1245-1248
[8]  
CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO
[9]  
2-H
[10]  
Chaudhry R, 2001, CAN MED ASSOC J, V164, P183